Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sawai Group Holdings CoSWGHF 53 Days Sales Outstanding is 90.53 as of Jun. 2026, which is 26% below its 10-year median of 122.52. GuruFocus rates SWGHF with a GF Score™ of 53/100 and a GF Value™ of $16.33. The stock has 4 warning signs investors should review. Among 945 Drug Manufacturers companies, Sawai Group Holdings Co ranks worse than 67.51% on this metric.
Sawai Group Holdings Co (OTCPK:SWGHF) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Sawai Group Holdings Co Days Sales Outstanding Related Terms
Sawai Group Holdings Co Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Sawai Group Holdings Co's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sawai Group Holdings Co Days Sales Outstanding Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Sawai Group Holdings Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sawai Group Holdings Co Days Sales Outstanding vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sawai Group Holdings Co's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Sawai Group Holdings Co's Days Sales Outstanding falls into.
Sawai Group Holdings Co Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sawai Group Holdings Co (SWGHF) has a Days Sales Outstanding of 90.53 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Sawai Group Holdings Co and its competitors. This is 26% below median its historical median of 122.52. Over the past decade, Sawai Group Holdings Co's Days Sales Outstanding has ranged from 90.88 to 147.23. According to the industry distribution chart, Sawai Group Holdings Co ranks #638 out of 945 companies in the Drug Manufacturers industry, placing it in the top 67.5%.
Is Sawai Group Holdings Co's Days Sales Outstanding too high?
Sawai Group Holdings Co's current Days Sales Outstanding of 90.53 is 26% below median its 10-year median of 122.52. Over the past 10 years, this metric has ranged from a low of 90.88 to a high of 147.23. The Drug Manufacturers industry median Days Sales Outstanding is 71.80. Sawai Group Holdings Co's value of 90.53 is 26.1% above this industry median. Based on the distribution chart, Sawai Group Holdings Co ranks #638 out of 945 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Sawai Group Holdings Co has a GF Score™ of 53/100, reflecting its overall financial health beyond just this single metric.
How does Sawai Group Holdings Co's Days Sales Outstanding compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Sawai Group Holdings Co ranks #638 out of 945 companies for Days Sales Outstanding. This places Sawai Group Holdings Co in the lower half of its industry. The industry median Days Sales Outstanding is 71.80. Sawai Group Holdings Co's value of 90.53 is 26.1% above this benchmark. Historically, Sawai Group Holdings Co's own Days Sales Outstanding has ranged from 90.88 to 147.23 over the past decade. While the company's 10-year median is 122.52 vs. the industry median of 71.80, Sawai Group Holdings Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Drug Manufacturers company?
The median Days Sales Outstanding among Drug Manufacturers companies is 71.80, based on 945 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sawai Group Holdings Co's current Days Sales Outstanding of 90.53 is 26.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Sawai Group Holdings Co and its competitors. For the Drug Manufacturers industry, the median Days Sales Outstanding is 71.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sawai Group Holdings Co's current Days Sales Outstanding is 90.53, which is 26% below median its own 10-year median of 122.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sawai Group Holdings Co stock overvalued right now?
Sawai Group Holdings Co (SWGHF) has a current Days Sales Outstanding of 90.53. The stock's GF Value™ is $16.33, compared to a current price of $11.52 — trading 29.5% below its estimated fair value. The current Days Sales Outstanding is 90.53, which is 26% below median its 10-year median of 122.52 and 26.1% above the Drug Manufacturers industry median of 71.80. Sawai Group Holdings Co's overall GF Score™ is 53/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Sawai Group Holdings Co (SWGHF), the current Days Sales Outstanding is 90.53 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sawai Group Holdings Co (SWGHF) Overvalued in 2026?
Based on GuruFocus' analysis, Sawai Group Holdings Co stock appears to be undervalued.
The current stock price of $11.52 is trading 29.5% below its estimated GF Value™ of $16.33.
Key valuation signals for SWGHF:
Days Sales Outstanding: 90.53 (26% below median its 10-year median of 122.52)
GF Value™: $16.33 vs. price of $11.52 (29.5% below fair value)
Industry Position: 26.1% above the Drug Manufacturers median (#638 of 945)
No single metric tells the full story. See the SWGHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sawai Group Holdings Co Ltd is engaged in providing management support or guidance to domestic and foreign companies engaged in businesses related to medical and healthcare services, such as the manufacture and sale of pharmaceutical products and medical equipment, as well as various businesses incidental or related to the same.
53GF Score
Get the complete analysis for SWGHF
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SWGHF has been successfully added to your 
